Patents by Inventor Philip W. Majerus

Philip W. Majerus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GRB2 associating polypeptides and nucleic acids encoding therefor
    Patent number: 6472197
    Abstract: The present invention generally relates to novel GRB2 associating proteins and nucleic acids which encode these protein. In particular, these novel proteins possess inositol polyphosphate 5-phosphatase and phosphatidylinositol 5-phosphatase activities, important in growth factor mediated signal transduction. As such, the proteins, nucleic acids encoding the proteins, cells capable of expressing these nucleic acids and antibodies specific for these proteins will find a variety of uses in a variety of screening, therapeutic and other applications.
    Type: Grant
    Filed: October 1, 2001
    Date of Patent: October 29, 2002
    Assignees: The Regents of the University of California, Washington University
    Inventors: David A. Pot, Lewis T. Williams, Anne Bennett Jefferson, Philip W. Majerus
  • NOVEL GRB2 ASSOCIATING POLYPEPTIDES AND NUCLEIC ACIDS ENCODING THEREFOR
    Publication number: 20020150567
    Abstract: The present invention generally relates to novel GRB2 associating proteins and nucleic acids which encode these protein. In particular, these novel proteins possess inositol polyphosphate 5-phosphatase and phosphatidylinositol 5-phosphatase activities, important in growth factor mediated signal transduction. As such, the proteins, nucleic acids encoding the proteins, cells capable of expressing these nucleic acids and antibodies specific for these proteins will find a variety of uses in a variety of screening, therapeutic and other applications.
    Type: Application
    Filed: October 1, 2001
    Publication date: October 17, 2002
    Applicant: The Regents of the University of California
    Inventors: David A. Pot, Lewis T. Williams, Anne Bennett Jefferson, Philip W. Majerus
  • GRB2 associating polypeptides and nucleic acids encoding therefor
    Patent number: 6296848
    Abstract: The present invention generally relates to novel GRB2 associating proteins and nucleic acids which encode these protein. In particular, these novel proteins possess inositol polyphosphate 5-phosphatase and phosphatidylinositol 5-phosphatase activities, important in growth factor mediated signal transduction. As such, the proteins, nucleic acids encoding the proteins, cells capable of expressing these nucleic acids and antibodies specific for these proteins will find a variety of uses in a variety of screening, therapeutic and other applications.
    Type: Grant
    Filed: October 14, 1999
    Date of Patent: October 2, 2001
    Assignee: The Regents of the University of California
    Inventors: David A. Pot, Lewis T. Williams, Anne Bennett Jefferson, Philip W. Majerus
  • GRB2 associating polypeptides and nucleic acids encoding therefor
    Patent number: 6001354
    Abstract: The present invention generally relates to novel GRB2 associating proteins and nucleic acids which encode these protein. In particular, these novel proteins possess inositol polyphosphate 5-phosphatase and phosphatidylinositol 5-phosphatase activities, important in growth factor mediated signal transduction. As such, the proteins, nucleic acids encoding the proteins, cells capable of expressing these nucleic acids and antibodies specific for these proteins will find a variety of uses in a variety of screening, therapeutic and other applications.
    Type: Grant
    Filed: November 17, 1995
    Date of Patent: December 14, 1999
    Assignees: Washington University, The Regents of the University of California
    Inventors: David A. Pot, Lewis T. Williams, Anne Bennett Jefferson, Philip W. Majerus
  • DNA clone of human thrombomodulin and portions thereof
    Patent number: 4912207
    Abstract: A cDNA having a base sequence for human thrombomodulin has been cloned and characterized and the amino acid sequence of the human thrombomodulin has been determined.
    Type: Grant
    Filed: May 6, 1987
    Date of Patent: March 27, 1990
    Assignee: Washington University
    Inventors: Philip W. Majerus, J. Evan Sadler